Teacher Retirement System of Texas grew its holdings in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) by 35.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 84,425 shares of the specialty chemicals company's stock after purchasing an additional 22,027 shares during the quarter. Teacher Retirement System of Texas owned approximately 0.34% of Innospec worth $6,462,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC increased its position in shares of Innospec by 1,159.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company's stock valued at $44,000 after purchasing an additional 487 shares during the last quarter. Versant Capital Management Inc increased its position in shares of Innospec by 378.1% during the 3rd quarter. Versant Capital Management Inc now owns 545 shares of the specialty chemicals company's stock valued at $42,000 after purchasing an additional 431 shares during the last quarter. Allworth Financial LP increased its position in shares of Innospec by 31.0% during the 3rd quarter. Allworth Financial LP now owns 588 shares of the specialty chemicals company's stock valued at $45,000 after purchasing an additional 139 shares during the last quarter. Danske Bank A S purchased a new stake in shares of Innospec during the 3rd quarter valued at about $46,000. Finally, State of Wyoming increased its position in shares of Innospec by 27.5% during the 2nd quarter. State of Wyoming now owns 801 shares of the specialty chemicals company's stock valued at $67,000 after purchasing an additional 173 shares during the last quarter. Hedge funds and other institutional investors own 96.64% of the company's stock.
Innospec Stock Performance
Innospec stock opened at $77.15 on Monday. The firm has a 50 day moving average of $74.50 and a 200 day moving average of $76.47. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 16.49, a P/E/G ratio of 2.07 and a beta of 0.90. Innospec Inc. has a 12-month low of $65.51 and a 12-month high of $95.55.
Innospec (NASDAQ:IOSP - Get Free Report) last released its earnings results on Tuesday, February 17th. The specialty chemicals company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.24. The company had revenue of $455.60 million during the quarter, compared to analyst estimates of $460.87 million. Innospec had a net margin of 6.56% and a return on equity of 10.18%. The firm's quarterly revenue was down 2.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.41 EPS. On average, analysts predict that Innospec Inc. will post 4.96 EPS for the current year.
Insider Activity
In related news, Director Milton C. Blackmore sold 594 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $76.56, for a total value of $45,476.64. Following the completion of the sale, the director directly owned 10,530 shares of the company's stock, valued at approximately $806,176.80. This represents a 5.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Larry Padfield sold 594 shares of the stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $76.56, for a total transaction of $45,476.64. Following the completion of the sale, the director directly owned 9,453 shares of the company's stock, valued at $723,721.68. This represents a 5.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 4,989 shares of company stock valued at $391,889. 1.45% of the stock is owned by insiders.
Analyst Ratings Changes
Several equities research analysts have recently commented on the stock. Zacks Research lowered shares of Innospec from a "hold" rating to a "strong sell" rating in a research report on Thursday, February 19th. Weiss Ratings raised shares of Innospec from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, February 19th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Reduce".
View Our Latest Research Report on Innospec
About Innospec
(
Free Report)
Innospec Incorporated NASDAQ: IOSP is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.
Featured Stories
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.